Page 248 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition

CHAPTER 13 Radiation Oncology 227

109. Wilson PF, Bedford JS: Radiobiological principles. In Hoppe RT, 131. LaDueMiller T, Price GS, Page RL, et al.: Radiotherapy of canine
Phillips TL, Roach III M, editors: Leibel and Phillips textbook of non-tonsillar squamous cell carcinoma, Vet Radiol Ultrasound
radiation oncology, ed 3, St. Louis, 2010, Elsevier, pp 3–30. 37:74–77, 1996.
VetBooks.ir 110. Fitzpatrick CL, Farese JP, Milner RJ, et al.: Intrinsic radiosensi- 132. Postorino-Reeves NC, Turrel JM, Withrow SJ: Oral squamous cell
carcinoma in the cat, J Am An Hosp Assoc 29:1–4, 1993.
tivity and repair of sublethal radiation-induced damage in canine
osteosarcoma cell lines, Am J Vet Res 69:1197–1202, 2008.
111. van den Aardweg GJMJ, Kilic E, de Klein N, et al.: Dose fraction- 133. Ogilvie GK, Moore AS, Obradovich JE: Toxicoses and efficacy
associated with administration of mitoxantrone to cats with malig-
ation effects in primary and metastatic human uveal melanoma cell nant tumors, J Am Vet Med Assoc 202:1839–1844, 1993.
lines, Invest Ophthalmol Vis Sci 44:4660–4664, 2003. 134. Hutson CA, Willauer CC, Walder EJ, et al.: Treatment of man-
112. Parfitt SL, Milner RJ, Salute ME, et al.: Radiosensitivity and dibular squamous cell carcinoma in cats by use of mandibulectomy
capacity for radiation-induced sublethal damage repair of canine and radiotherapy: seven cases (1987-1989), J Am Vet Med Assoc
transitional cell carcinoma (TCC) cell lines, Vet Comp Oncol 201:777–781, 1992.
9:232–240, 2011. 135. Fidel JL, Sellon RK, Houston RK, et al.: A nine-day accelerated
113. van Leeuwen CM, Oei AL, Crezee J, et al.: The alfa and beta of radiation protocol for feline squamous cell carcinoma, Vet Radiol
tumours: a review of parameters of the linear-quadratic model, Ultrasound 48:482–485, 2007.
derived from clinical radiotherapy studies, Radiat Oncol 13:96, 136. Yoshikawa H, Ehrhart EJ, Charles JB, et al.: Assessment of pre-
2018. dictive molecular variables in feline oral squamous cell carcinoma
114. Buchholz J, Hagen R, Leo C, et al.: 3D conformal radiation treated with stereotactic radiation therapy, Vet Comp Oncol 14:39–
therapy for palliative treatment of canine nasal tumors, Vet Radiol 57, 2016.
Ultrasound 50:679–683, 2009. 137. McChesney SL, Withrow SJ, Gillette EL, et al.: Radiotherapy of
115. Bregazzi VS, LaRue SM, Powers BE, et al.: Response of feline oral soft tissue sarcomas in dogs, J Am Vet Med Assoc 194:60–63, 1989.
squamous cell carcinoma to palliative radiation therapy, Vet Radiol 138. Gillette SM, Dewhirst MW, Gillette EL, et al.: Response of canine
Ultrasound 42:77–79, 2001. soft tissue sarcomas to radiation or radiation plus hyperthermia: a
116. Hillers KR, Lana SE, Fuller CR, et al.: Effects of palliative radiation randomized phase II study, Int J Hyperthermia 8:309–320, 1992.
therapy on nonsplenic hemangiosarcoma in dogs, J Am Anim Hosp 139. Forrest LJ, Chun R, Adams WM, et al.: Postoperative radiotherapy
Assoc 43:187–192, 2007. for canine soft tissue sarcoma, J Vet Intern Med 14:578–582, 2000.
117. Parshley DL, LaRue SM, Kitchell B, et al.: Abdominal irradiation as 140. Todoroff RJ, Brodey RS: Oral and pharyngeal neoplasia in the dog:
a rescue therapy for feline gastrointestinal lymphoma: a retrospective a retrospective survey of 361 cases, J Am Vet Med Assoc 175:567–
study of 11 cats (2001-2008), J Feline Med Surg 13:63–68, 2011. 571, 1979.
118. Ramirez III O, Dodge RK, Page RL, et al.: Palliative radiotherapy 141. Proulx DR, Ruslander DM, Dodge RK, et al.: A retrospective anal-
of appendicular osteosarcoma in 95 dogs, Vet Radiol Ultrasound ysis of 140 dogs with oral melanoma treated with external beam
40:517–522, 1999. radiation, Vet Radiol Ultrasound 44:352–359, 2003.
119. Einstein A: Concerning an heuristic point of view toward the emis- 142. Freeman KP, Hahn KA, Harris FD, et al.: Treatment of dogs with
sion and transformation of light, Ann Phys 17:132–148, 1905. oral melanoma by hypofractionated radiation therapy and plati-
120. Barak F, Werner A, Walach N, et al.: Extensive late bone necrosis num-based chemotherapy (1987-1997), J Vet Intern Med 17:96–
after postoperative orthovoltage irradiation of breast carcinoma. 101, 2003.
Report of a case, Acta Radiol Oncol 23:485–488, 1984. 143. Farrelly J, Denman DL, Hohenhaus AE, et al.: Hypofractionated
121. Ling CC, Humm J, Larson S, et al.: Towards multidimensional radiation therapy of oral melanoma in five cats, Vet Radiol Ultra-
radiotherapy (MD-CRT): biological imaging and biological con- sound 45:91–93, 2004.
formality, Int J Radiat Oncol Biol Phys 47:551–560, 2000. 144. Bentzen SM, Overgaard J, Thames HD, et al.: Clinical radiobiol-
122. Hunley DW, Mauldin GN, Shiomitsu K, et al.: Clinical outcome ogy of malignant melanoma, Radiother Oncol 16:169–182, 1989.
in dogs with nasal tumors treated with intensity-modulated radia- 145. Burris III HA, Hurtig J: Radiation recall with anticancer agents,
tion therapy, Can Vet J 51:293–300, 2010. Oncologist 15:1227–1237, 2010.
123. Lawrence JA, Forrest LJ, Turek MM, et al.: Proof of principle of 146. van der Veen J, Nuyts S: Can intensity-modulated-radiotherapy
ocular sparing in dogs with sinonasal tumors treated with inten- reduce toxicity in head and neck squamous cell carcinoma? Cancers
sity-modulated radiation therapy, Vet Radiol Ultrasound 51:561– (Basel) 9:E135, 2017.
570, 2010. 147. Ghosh-Laskar S, Yathiraj PH, Dutta D, et al.: Prospective random-
124. Nolan MW, Custis JT, Harmon JF, et al.: Intensity-modulated ized controlled trial to compare 3-dimensional conformal radio-
radiation therapy for local control of canine urogenital carcinomas, therapy to intensity-modulated radiotherapy in head and neck
J Vet Intern Med 26:987–995, 2012. squamous cell carcinoma: Long-term results, Head Neck 38(Suppl
125. Mendenhall WM, Dagan R, Bryant CM, et al.: Radiation oncology 1):E1481–E1487, 2016.
for head and neck cancer: current standards and future changes, 148. Kuhnt T, Stang A, Wienke A, et al.: Potential risk factors for jaw
Oral Maxillofac Surg Clin North Am 31:31–38, 2019. osteoradionecrosis after radiotherapy for head and neck cancer,
126. Thrall DE: Orthovoltage radiotherapy of acanthomatous epulides Radiat Oncol 11:101, 2016.
in 39 dogs, J Am Vet Med Assoc 184:826–829, 1984. 149. Siddiqui F, Patel M, Khan M, et al.: Stereotactic body radiation
127. Theon AP, Rodriguez C, Griffey S, et al.: Analysis of prognostic factors therapy for primary, recurrent, and metastatic tumors in the head-
and patterns of failure in dogs with periodontal tumors treated with and-neck region, Int J Radiat Oncol Biol Phys 74:1047–1053, 2009.
megavoltage irradiation, J Am Vet Med Assoc 210:785–788, 1997. 150. Hahn KA, Knapp DW, Richardson RC, et al.: Clinical response of
128. McEntee MC, Page RL, Theon A, et al.: Malignant tumor forma- nasal adenocarcinoma to cisplatin chemotherapy in 11 dogs, J Am
tion in dogs previously irradiated for acanthomatous epulis, Vet Vet Med Assoc 200:355–357, 1992.
Radiol Ultrasound 45:357–361, 2004. 151. Henry CJ, Brewer Jr WG, Tyler JW, et al.: Survival in dogs with
129. Evans SM, Shofer F: Canine oral nontonsillar squamous cell car- nasal adenocarcinoma: 64 cases (1981-1995), J Vet Intern Med
cinomas: prognostic factors for recurrence and survival following 12:436–439, 1998.
orthovoltage radiation therapy, Vet Radiol 29:133–137, 1988. 152. Holmberg DL, Fries C, Cockshutt J, et al.: Ventral rhinotomy in
130. Theon AP, Rodriquez C, Madewell BR: Analysis of prognostic the dog and cat, Vet Surg 18:446–449, 1989.
factors and patterns of failure in dogs with malignant oral tumors 153. Langova V, Mutsaers AJ, Phillips B, et al.: Treatment of eight dogs with
treated with megavoltage irradiation, J Am Vet Med Assoc 210:778– nasal tumours with alternating doses of doxorubicin and carboplatin in
784, 1997. conjunction with oral piroxicam, Aust Vet J 82:676–680, 2004.